Omnicell Inc. Stock
Omnicell Inc. Stock
Heavy losses for Omnicell Inc. today as the stock fell by -€3.800 (-10.670%).
With 11 Buy predictions and not the single Sell prediction the community is currently very high on Omnicell Inc..
With a target price of 47 € there is a positive potential of 47.8% for Omnicell Inc. compared to the current price of 31.8 €.
So far the community has only identified positive things for Omnicell Inc. stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".
Pros and Cons of Omnicell Inc. in the next few years
Pros
?
M***** P*******
?
B****
?
C******** o* t** e**********
Cons
?
W********* I********* f** t** n*** y****
?
S********** s********
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Omnicell Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Omnicell Inc. | -10.670% | -10.674% | -10.169% | 17.778% | -18.041% | -44.211% | -73.051% |
| Healthequity Inc. | -3.310% | 6.707% | 11.465% | 2.941% | 12.179% | 49.573% | 40.585% |
| Bruker Corp. | -3.550% | 2.445% | 3.417% | 61.758% | 33.562% | -13.524% | - |
| Myriad Genetics | 3.610% | -7.568% | -6.972% | 30.424% | -12.887% | -76.915% | -82.740% |
Comments
Omnicell (OMCL) had its "overweight" rating reaffirmed by Wells Fargo & Company.
Show more
Ratings data for OMCL provided by MarketBeat
Omnicell (OMCL) had its price target lowered by KeyCorp from $70.00 to $65.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for OMCL provided by MarketBeat
Omnicell (OMCL) had its "buy" rating reaffirmed by Craig Hallum.
Show more
Ratings data for OMCL provided by MarketBeat
News
Omnicell Q2 Earnings Call Highlights
Key Points
- Interested in Omnicell, Inc.? Here are five stocks we like better.
- Omnicell exceeded profitability expectations in Q2 2026, reporting $312 million in revenue, $67 million in
Investment Advisor Sells $6.6 Million Worth of Medical Solutions Stock, According to Recent SEC Filing
On April 29, 2026, Avory & Company, LLC disclosed in a U.S. Securities and Exchange Commission (SEC) filing that it sold 156,571 shares of Omnicell (NASDAQ:OMCL), an estimated $6.55 million
Why Omnicell Stock Trounced the Market on Tuesday
Omnicell (NASDAQ: OMCL) is off to a roaring start this year, at least as far as its quarterly performance is concerned. On Tuesday, it published its first earnings report of the year, and Mr. Market